Federal Cannabis Prohibition Persists Despite 38-State Legal Markets

Federal Schedule I Status Unchanged

The Drug Enforcement Administration continues to classify cannabis as a Schedule I controlled substance with no accepted medical use and high abuse potential. This classification places cannabis in the same legal category as heroin and LSD under the Controlled Substances Act of 1970. The Biden administration's 2024 proposal to reschedule cannabis to Schedule III hasn't been finalized, leaving the federal prohibition fully intact as of May 2026.

Federal law criminalizes the manufacture, distribution, and possession of cannabis regardless of state legal frameworks. First-time possession carries up to five years imprisonment. Cultivation and distribution offenses trigger mandatory minimum sentences.

State-Legal Markets Operate in Legal Gray Zone

Thirty-eight states have enacted medical or adult-use cannabis programs that directly conflict with federal statute. Twenty-four states permit adult-use sales. Fourteen additional states authorize medical cannabis only. These state programs license cultivation, processing, testing, and retail operations that federal law categorizes as drug trafficking.

State-licensed operators face prosecution risk under federal law. The cleanest read on current enforcement posture is selective non-intervention: the Department of Justice has deprioritized prosecution of state-compliant operators since the 2013 Cole Memo, but that guidance was rescinded in 2018 and never restored. No formal safe harbor exists.

Federal enforcement discretion shifts with each new administration. Operators in state-legal markets work under revocable tolerance, not legal protection.

Banking and Tax Penalties Stem from Federal Status

Federal prohibition blocks cannabis businesses from accessing traditional banking services and imposes punitive tax treatment under Internal Revenue Code Section 280E. Most federally insured banks refuse deposit accounts or merchant services to cannabis operators due to Bank Secrecy Act compliance risk and potential money laundering liability under 18 U.S.C. § 1956.

Section 280E prohibits businesses trafficking in Schedule I or II substances from deducting ordinary business expenses. Cannabis retailers pay effective federal tax rates exceeding 70 percent on gross profit. A California dispensary reporting $2 million in revenue and $1.5 million in operating expenses can't deduct rent, payroll, or utilities—resulting in federal tax liability on $2 million rather than $500,000 in actual profit.

The SAFE Banking Act would provide a federal safe harbor for financial institutions serving state-legal cannabis businesses. It's passed the House seven times since 2019. The Senate has never cleared it.

Interstate Commerce Remains Federally Prohibited

Cannabis can't cross state lines under any circumstance without violating federal law, even between two states with legal adult-use programs. The Commerce Clause grants Congress exclusive authority over interstate trade. Transporting cannabis from Oregon to California—both adult-use states—constitutes federal drug trafficking under 21 U.S.C. § 841.

This prohibition fragments the national market into 38 separate state silos. Cultivators in low-cost production states can't ship to high-demand coastal markets. Patients can't transport medical cannabis across state lines, even with valid registry cards in both jurisdictions.

For more background on the federal-state legal split, see the CannIntel topic hub on federal cannabis legality.

Rescheduling Would Not Legalize Cannabis

The pending DEA proposal to move cannabis from Schedule I to Schedule III would reduce some penalties but wouldn't remove federal prohibition. Schedule III substances—including ketamine, anabolic steroids, and Tylenol with codeine—remain controlled. Manufacture and distribution require DEA registration. Possession without a valid prescription remains a federal crime.

Rescheduling would eliminate 280E tax penalties and could open pathways for FDA-approved cannabis medicines, but it wouldn't authorize state recreational markets or resolve the banking impasse. Adult-use dispensaries would still operate in violation of federal law.

Federal Legalization Requires Congressional Action

Only Congress can remove cannabis from the Controlled Substances Act and establish a federal regulatory framework for state-legal markets. The Cannabis Administration and Opportunity Act, introduced in 2022, would deschedule cannabis entirely and create a federal excise tax structure, but the bill hasn't advanced to a floor vote in either chamber.

Bipartisan support exists for incremental reforms—banking access, veterans' medical access, expungement—but not for full descheduling. The votes aren't there yet. The political arithmetic hasn't shifted enough to move comprehensive legalization through a divided Congress.

Until federal law changes, the answer to whether cannabis is legal in the United States remains unambiguous: no. State programs operate in defiance of federal statute, not under its protection.